sintilimab Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1 (1)
Phase 2 (1)

Interventional (2)

Innovent Biologics (Suzhou) Co. Ltd. (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadplatelet count

I am/have/hadsmall cell lung cancer

I am/have/hadtransient ischemic attack

I am/have/hadlung cancer

I am/have/hadcancer

I am/have/hadunstable angina

I am/have/hadblood test

I am/have/hadliver disease

I am/have/hadproteinuria

I am/have/hadpneumonia

I am/have/hadstroke

I am/have/hadpulmonary disease

I am/have/hadmental illness

I am/have/hadhepatitis

I am/have/hadblood pregnancy test

I am/have/haddiabetes

I am/have/hadneutrophil count

I am/have/hadnon-small cell lung cancer

I am/have/hadangina pectoris

I am/have/hadinterstitial lung disease

added new label for I am/have/had

more

I am looking for

I am looking forgranulocyte colony stimulating factor

I am looking forcolony stimulating factor

I am looking forsintilimab

I am looking forpemetrexed

I am looking forg-csf

I am looking forcarboplatin

I am looking forpaclitaxel

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Family Medicine
Recruiting

Neoadjuvant of Sintilimab Combined With Chemotherapy for Resectable NSCLC neoSCORE

This is a Phase 2, prospective, randomized, open-Label, single-center international study that assesses the efficacy and safety of neoadjuvant therapy with different cycles of sintilimab combined with chemotherapy for resectable NSCLC. This trial will also explore the biomarkers of neoadjuvant immunochemotherapy.

granulocyte colony stimulating factor

paclitaxel

platelet count

small cell lung cancer

carboplatin

0 views
19 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Ib Study of the Efficacy and Safety of IBI310 Combined With Sintilimab in Advanced Hepatocellular Carcinoma

An open-label, single-arm, Ib study of the efficacy and safety of IBI310 combined with sintilimab in patients with advanced hepatocellular carcinoma

0 views
19 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.